465 related articles for article (PubMed ID: 32169474)
1. Poloxamer 188-mediated anti-inflammatory effect rescues cognitive deficits in paraquat and maneb-induced mouse model of Parkinson's disease.
Ding W; Lin H; Hong X; Ji D; Wu F
Toxicology; 2020 Apr; 436():152437. PubMed ID: 32169474
[TBL] [Abstract][Full Text] [Related]
2. Taurine improves neuron injuries and cognitive impairment in a mouse Parkinson's disease model through inhibition of microglial activation.
Wang K; Shi Y; Liu W; Liu S; Sun MZ
Neurotoxicology; 2021 Mar; 83():129-136. PubMed ID: 33450328
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of NLRP3 inflammasome by glibenclamide attenuated dopaminergic neurodegeneration and motor deficits in paraquat and maneb-induced mouse Parkinson's disease model.
Qiu X; Wang Q; Hou L; Zhang C; Wang Q; Zhao X
Toxicol Lett; 2021 Oct; 349():1-11. PubMed ID: 34052309
[TBL] [Abstract][Full Text] [Related]
4. Lesion of the Locus Coeruleus Damages Learning and Memory Performance in Paraquat and Maneb-induced Mouse Parkinson's Disease Model.
Hou L; Sun F; Sun W; Zhang L; Wang Q
Neuroscience; 2019 Nov; 419():129-140. PubMed ID: 31634513
[TBL] [Abstract][Full Text] [Related]
5. Poloxamer 188 rescues MPTP-induced lysosomal membrane integrity impairment in cellular and mouse models of Parkinson's disease.
Dong H; Qin Y; Huang Y; Ji D; Wu F
Neurochem Int; 2019 Jun; 126():178-186. PubMed ID: 30904670
[TBL] [Abstract][Full Text] [Related]
6. Eupatilin prevents behavioral deficits and dopaminergic neuron degeneration in a Parkinson's disease mouse model.
Zhang Y; Qin L; Xie J; Li J; Wang C
Life Sci; 2020 Jul; 253():117745. PubMed ID: 32376269
[TBL] [Abstract][Full Text] [Related]
7. Integrin CD11b mediates locus coeruleus noradrenergic neurodegeneration in a mouse Parkinson's disease model.
Hou L; Qu X; Qiu X; Huang R; Zhao X; Wang Q
J Neuroinflammation; 2020 May; 17(1):148. PubMed ID: 32375810
[TBL] [Abstract][Full Text] [Related]
8. FTY720 Inhibits MPP
Yao S; Li L; Sun X; Hua J; Zhang K; Hao L; Liu L; Shi D; Zhou H
J Neuroimmune Pharmacol; 2019 Sep; 14(3):478-492. PubMed ID: 31069623
[TBL] [Abstract][Full Text] [Related]
9. Enhancement of ATP production ameliorates motor and cognitive impairments in a mouse model of MPTP-induced Parkinson's disease.
Haga H; Matsuo K; Yabuki Y; Zhang C; Han F; Fukunaga K
Neurochem Int; 2019 Oct; 129():104492. PubMed ID: 31229554
[TBL] [Abstract][Full Text] [Related]
10. Combined 1-Deoxynojirimycin and Ibuprofen Treatment Decreases Microglial Activation, Phagocytosis and Dopaminergic Degeneration in MPTP-Treated Mice.
Costa T; Fernandez-Villalba E; Izura V; Lucas-Ochoa AM; Menezes-Filho NJ; Santana RC; de Oliveira MD; Araújo FM; Estrada C; Silva V; Costa SL; Herrero MT
J Neuroimmune Pharmacol; 2021 Jun; 16(2):390-402. PubMed ID: 32564332
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of NADPH oxidase by apocynin prevents learning and memory deficits in a mouse Parkinson's disease model.
Hou L; Sun F; Huang R; Sun W; Zhang D; Wang Q
Redox Biol; 2019 Apr; 22():101134. PubMed ID: 30798073
[TBL] [Abstract][Full Text] [Related]
12. Anesthetic Effects on the Progression of Parkinson Disease in the Rat DJ-1 Model.
Xu DA; DeYoung TP; Kondoleon NP; Eckenhoff RG; Eckenhoff MF
Anesth Analg; 2021 Nov; 133(5):1140-1151. PubMed ID: 34673725
[TBL] [Abstract][Full Text] [Related]
13. Microglial activation contributes to cognitive impairments in rotenone-induced mouse Parkinson's disease model.
Zhang D; Li S; Hou L; Jing L; Ruan Z; Peng B; Zhang X; Hong JS; Zhao J; Wang Q
J Neuroinflammation; 2021 Jan; 18(1):4. PubMed ID: 33402167
[TBL] [Abstract][Full Text] [Related]
14. Neuroprotective effects of acetyl-l-carnitine (ALC) in a chronic MPTP-induced Parkinson's disease mouse model: Endothelial and microglial effects.
Burks S; Raymick J; Robinson B; Hanig J; Sarkar S
Neurosci Lett; 2019 Jun; 703():86-95. PubMed ID: 30890473
[TBL] [Abstract][Full Text] [Related]
15. Assessment of the Effects of MPTP and Paraquat on Dopaminergic Neurons and Microglia in the Substantia Nigra Pars Compacta of C57BL/6 Mice.
Smeyne RJ; Breckenridge CB; Beck M; Jiao Y; Butt MT; Wolf JC; Zadory D; Minnema DJ; Sturgess NC; Travis KZ; Cook AR; Smith LL; Botham PA
PLoS One; 2016; 11(10):e0164094. PubMed ID: 27788145
[TBL] [Abstract][Full Text] [Related]
16. Selective loss of dopaminergic neurons in the substantia nigra pars compacta after systemic administration of MPTP facilitates extinction learning.
Kinoshita K; Tada Y; Muroi Y; Unno T; Ishii T
Life Sci; 2015 Sep; 137():28-36. PubMed ID: 26209139
[TBL] [Abstract][Full Text] [Related]
17. TLR4 deficiency has a protective effect in the MPTP/probenecid mouse model of Parkinson's disease.
Shao QH; Chen Y; Li FF; Wang S; Zhang XL; Yuan YH; Chen NH
Acta Pharmacol Sin; 2019 Dec; 40(12):1503-1512. PubMed ID: 31388087
[TBL] [Abstract][Full Text] [Related]
18. Taurine protects dopaminergic neurons in a mouse Parkinson's disease model through inhibition of microglial M1 polarization.
Che Y; Hou L; Sun F; Zhang C; Liu X; Piao F; Zhang D; Li H; Wang Q
Cell Death Dis; 2018 Apr; 9(4):435. PubMed ID: 29568078
[TBL] [Abstract][Full Text] [Related]
19. Effects of ceftriaxone on the behavioral and neuronal changes in an MPTP-induced Parkinson's disease rat model.
Ho SC; Hsu CC; Pawlak CR; Tikhonova MA; Lai TJ; Amstislavskaya TG; Ho YJ
Behav Brain Res; 2014 Jul; 268():177-84. PubMed ID: 24755306
[TBL] [Abstract][Full Text] [Related]
20. Integrin Mac1 mediates paraquat and maneb-induced learning and memory impairments in mice through NADPH oxidase-NLRP3 inflammasome axis-dependent microglial activation.
Hou L; Liu J; Sun F; Huang R; Chang R; Ruan Z; Wang Y; Zhao J; Wang Q
J Neuroinflammation; 2023 Feb; 20(1):42. PubMed ID: 36804009
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
